Bayer gets industry discredit ruling overturned after accusation of ‘warming the market’ for Eylea launch
Bayer has overturned a ruling that it brought discredit on the pharma industry. Accused of “warming the market” for a new Eylea indication, the German drugmaker successfully argued on appeal that an advisory board was in fact legitimate.
